Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Head Neck. 2018 Dec 7;41(2):479–487. doi: 10.1002/hed.25412

Table 1.

Patient characteristics (n=16,194)

No (%)
Sex
Female 5,606 (34.62)
Male 10,588 (65.38)
Race/Ethnicity
Caucasian 13,709 (84.65)
Black 1,001 (6.18)
Hispanic 763 (4.71)
Other 721 (4.45)
Age quartiles
<69 3,111 (19.21)
69–74 4,674 (28.86)
74–79 3,722 (22.98)
>79 4,687 (28.94)
Disease sub-site
Oral cavity 6,371 (39.34)
Larynx 5,521 (34.09)
Oropharynx 1,308 (8.08)
Nasopharynx 360 (2.22)
Missing 2,634 (16.27)
SEER stage
In situ/Localized 5,349 (33.03)
Regional 5,131 (31.68)
Distant 1,372 (8.47)
Unstaged/Missing 4,342 (26.81)
Comorbidity
0 9,340 (57.68)
1 4,123 (25.46)
2 2,731 (16.86)
Treatment Modality
Surgery alone 4,147 (25.61)
Surgery + adjuvant therapy 4,430 (27.36)
Radiation alone 4,130 (25.50)
Chemoradiation 3,487 (21.53)
2-Year Prevalence (95% CI)
Dysphagia 7,335 (45.29)
Stricture 1,649 (10.18)
Pneumonia 4,252 (26.26)
Aspiration pneumonia 1,400 (8.65)
Total 16,194